The role of metastasectomy in renal cell carcinoma

References

• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127(12), 2893–2917 (2010).
   PubMed Web of Science ®Google Scholar
• Mathew A, Devesa SS, Fraumeni JF, Chow WH. Global increases in kidney cancer incidence, 1973–1992. Eur. J. Cancer Prev. 11(2), 171–178 (2002).
   PubMed Web of Science ®Google Scholar
• Cancer Research UK. Kidney Cancer Incidence Statistics. Cancer Research UK, London (2010).
   Google Scholar
• Sun M, Thuret R, Abdollah F et al. Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. Eur. Urol. 59(1), 135–141 (2011).
   Google Scholar
• Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat. Rev. 34(3), 193–205 (2008).
   PubMed Web of Science ®Google Scholar
• Leibovich BC, Blute ML, Cheville JC et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 97(7), 1663–1671 (2003).
   PubMed Web of Science ®Google Scholar
• Escudier B, Albiges L, Sonpavde G. Optimal management of metastatic renal cell carcinoma: current status. Drugs 73(5), 427–438 (2013).
   PubMed Web of Science ®Google Scholar
• Karam JA, Rini BI, Varella L et al. Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma. J. Urol. 185(2), 439–444 (2011).
   PubMed Web of Science ®Google Scholar
• Karam JA, Wood CG. The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy. Hematol. Oncol. Clin. North Am. 25(4), 753–764 (2011).
   Google Scholar
• Breau RH, Blute ML. Surgery for renal cell carcinoma metastases. Curr. Opin. Urol. 20(5), 375–381 (2010).
   Google Scholar
• Gazelle GS, Hunink MG, Kuntz KM et al. Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis. Ann. Surg. 237(4), 544–555 (2003).
   PubMed Web of Science ®Google Scholar
• Treasure T. Pulmonary metastasectomy: a common practice based on weak evidence. Ann. R Coll. Surg. Engl. 89(8), 744–748 (2007).
   Google Scholar
• Fong Y, Cohen AM, Fortner JG et al. Liver resection for colorectal metastases. J. Clin. Oncol. 15(3), 938–946 (1997).
   PubMed Web of Science ®Google Scholar
• Treasure T. Pulmonary metastasectomy for colorectal cancer: weak evidence and no randomised trials. Eur. J. Cardiothorac. Surg. 33(2), 300–302 (2008).
   PubMed Web of Science ®Google Scholar
• Treasure T, Fallowfield L, Lees B, Farewell V. Pulmonary metastasectomy in colorectal cancer: the PulMiCC trial. Thorax 67(2), 185–187 (2012).
   PubMed Web of Science ®Google Scholar
• Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N. Engl. J. Med. 335(12), 865–875 (1996).
   PubMed Web of Science ®Google Scholar
• Leibovich BC, Cheville JC, Lohse CM et al. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. J. Urol. 174(5), 1759–1763, discussion 1763 (2005).
   Google Scholar
• Dekernion JB, Ramming KP, Smith RB. The natural history of metastatic renal cell carcinoma: a computer analysis. J. Urol. 120(2), 148–152 (1978).
   Google Scholar
• Piltz S, Meimarakis G, Wichmann MW, Hatz R, Schildberg FW, Fuerst H. Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann. Thorac. Surg. 73(4), 1082–1087 (2002).
   PubMed Web of Science ®Google Scholar
• Pfannschmidt J, Hoffmann H, Muley T, Krysa S, Trainer C, Dienemann H. Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma. Ann. Thorac. Surg. 74(5), 1653–1657 (2002).
   PubMed Web of Science ®Google Scholar
• Murthy SC, Kim K, Rice TW et al. Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma? Ann. Thorac. Surg. 79(3), 996–1003 (2005).
   PubMed Web of Science ®Google Scholar
• Friedel G, Hürtgen M, Penzenstadler M, Kyriss T, Toomes H. Resection of pulmonary metastases from renal cell carcinoma. Anticancer Res. 19(2C), 1593–1596 (1999).
   Web of Science ®Google Scholar
• Cerfolio RJ, Allen MS, Deschamps C et al. Pulmonary resection of metastatic renal cell carcinoma. Ann. Thorac. Surg. 57(2), 339–344 (1994).
   PubMed Web of Science ®Google Scholar
• Hofmann HS, Neef H, Krohe K, Andreev P, Silber RE. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur. Urol. 48(1), 77–81, discussion 81–72 (2005).
   PubMed Web of Science ®Google Scholar
• Kandioler D, Krömer E, Tüchler H et al. Long-term results after repeated surgical removal of pulmonary metastases. Ann. Thorac. Surg. 65(4), 909–912 (1998).
   Google Scholar
• Kudelin N, Bölükbas S, Eberlein M, Schirren J. Metastasectomy with standardized lymph node dissection for metastatic renal cell carcinoma: an 11-year single-center experience. Ann. Thorac. Surg. 96(1), 265–271 (2013).
   Google Scholar
• Renaud S, Falcoz PE, Olland A, Massard G. Should mediastinal lymphadenectomy be performed during lung metastasectomy of renal cell carcinoma? Interact. Cardiovasc. Thorac. Surg. 16(4), 525–528 (2013).
   Google Scholar
• Sahi C, Knox JJ, Clemons M, Joshua AM, Broom R. Renal cell carcinoma bone metastases: clinical advances. Ther. Adv. Med. Oncol. 2(2), 75–83 (2010).
   PubMedGoogle Scholar
• Zekri J, Ahmed N, Coleman RE, Hancock BW. The skeletal metastatic complications of renal cell carcinoma. Int. J. Oncol. 19(2), 379–382 (2001).
   Google Scholar
• Jackson RJ, Loh SC, Gokaslan ZL. Metastatic renal cell carcinoma of the spine: surgical treatment and results. J. Neurosurg. 94(1 Suppl.), 18–24 (2001).
   Google Scholar
• Lin PP, Mirza AN, Lewis VO et al. Patient survival after surgery for osseous metastases from renal cell carcinoma. J. Bone Joint Surg. Am., 89(8), 1794–1801 (2007).
   PubMed Web of Science ®Google Scholar
• Kollender Y, Bickels J, Price WM et al. Metastatic renal cell carcinoma of bone: indications and technique of surgical intervention. J. Urol. 164(5), 1505–1508 (2000).
   Google Scholar
• Hatzaras I, Gleisner AL, Pulitano C et al. A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer. HPB (Oxford) 14(8), 532–538 (2012).
   Google Scholar
• Ruys AT, Tanis PJ, Iris ND et al. Surgical treatment of renal cell cancer liver metastases: a population-based study. Ann. Surg. Oncol. 18(7), 1932–1938 (2011).
   Google Scholar
• Staehler MD, Kruse J, Haseke N et al. Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J. Urol. 28(4), 543–547 (2010).
   PubMed Web of Science ®Google Scholar
• Reddy S, Wolfgang CL. The role of surgery in the management of isolated metastases to the pancreas. Lancet Oncol. 10(3), 287–293 (2009).
   PubMed Web of Science ®Google Scholar
• Niess H, Conrad C, Kleespies A et al. Surgery for metastasis to the pancreas: is it safe and effective? J. Surg. Oncol. 107(8), 859–864 (2013).
   Google Scholar
• Kim YZ, Kim KH, Kim JS, Song YJ, Kim KU, Kim HD. Clinical analysis of patients who survived for less than 3 months after brain metastatectomy. J. Korean Med. Sci. 24(4), 641–648 (2009).
   Google Scholar
• Shuch B, La Rochelle JC, Klatte T et al. Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival. Cancer 113(7), 1641–1648 (2008).
   PubMed Web of Science ®Google Scholar
• Wroński M, Arbit E, Russo P, Galicich JH. Surgical resection of brain metastases from renal cell carcinoma in 50 patients. Urology 47(2), 187–193 (1996).
   PubMed Web of Science ®Google Scholar
• Nieder C, Spanne O, Nordøy T, Dalhaug A. Treatment of brain metastases from renal cell cancer. Urol. Oncol. 29(4), 405–410 (2011).
   Google Scholar
• NCCN Clinical Practice Guidelines in Oncology on Central Nervous System Cancers. Version 2. 2013.
   Google Scholar
• Saitoh H, Nakayama M, Nakamura K, Satoh T. Distant metastasis of renal adenocarcinoma in nephrectomized cases. J. Urol. 127(6), 1092–1095 (1982).
   Google Scholar
• Lau WK, Zincke H, Lohse CM, Cheville JC, Weaver AL, Blute ML. Contralateral adrenal metastasis of renal cell carcinoma: treatment, outcome and a review. BJU Int. 91(9), 775–779 (2003).
   Google Scholar
• Antonelli A, Cozzoli A, Simeone C et al. Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients. BJU Int. 97(3), 505–508 (2006).
   PubMed Web of Science ®Google Scholar
• Kim B, Louie AC. Surgical resection following interleukin 2 therapy for metastatic renal cell carcinoma prolongs remission. Arch. Surg. 127(11), 1343–1349 (1992).
   Google Scholar
• Krishnamurthi V, Novick AC, Bukowski RM. Efficacy of multimodality therapy in advanced renal cell carcinoma. Urology 51(6), 933–937 (1998).
   Google Scholar
• Sella A, Swanson DA, Ro JY et al. Surgery following response to interferon-alpha-based therapy for residual renal cell carcinoma. J. Urol. 149(1), 19–21, discussion 21–22 (1993).
   Google Scholar
• Tanguay S, Swanson DA, Putnam JB. Renal cell carcinoma metastatic to the lung: potential benefit in the combination of biological therapy and surgery. J. Urol. 156(5), 1586–1589 (1996).
   PubMed Web of Science ®Google Scholar
• Lee DS, White DE, Hurst R, Rosenberg SA, Yang JC. Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy. Cancer J. Sci. Am. 4(2), 86–93 (1998).
   Google Scholar
• Bose D, Meric-Bernstam F, Hofstetter W, Reardon DA, Flaherty KT, Ellis LM. Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care. Lancet Oncol. 11(4), 373–382 (2010).
   Google Scholar
• Margulis V, Matin SF, Tannir N et al. Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma. J. Urol. 180(1), 94–98 (2008).
   PubMed Web of Science ®Google Scholar
• Cowey CL, Amin C, Pruthi RS et al. Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma. J. Clin. Oncol. 28(9), 1502–1507 (2010).
   PubMed Web of Science ®Google Scholar
• Shaw GL, Hussain M, Nair R et al. Performing cytoreductive nephrectomy following targeted sunitinib therapy for metastatic renal cell carcinoma: a surgical perspective. Urol. Int. 89(1), 83–88 (2012).
   Google Scholar
• Firek P, Richter S, Jaekel J, Brehmer B, Heidenreich A. [Metastasectomy in renal cell cancer after neoadjuvant therapy with multi-tyrosine kinase inhibitors]. Urologe A 51(3), 398–402 (2012).
   Google Scholar
• Thomas AA, Rini BI, Stephenson AJ et al. Surgical resection of renal cell carcinoma after targeted therapy. J Urol, 182(3), 881–886 (2009).
   PubMed Web of Science ®Google Scholar
• Assouad J, Petkova B, Berna P, Dujon A, Foucault C, Riquet M. Renal cell carcinoma lung metastases surgery: pathologic findings and prognostic factors. Ann. Thorac. Surg. 84(4), 1114–1120 (2007).
   PubMed Web of Science ®Google Scholar
• Winter H, Meimarakis G, Angele MK et al. Tumor infiltrated hilar and mediastinal lymph nodes are an independent prognostic factor for decreased survival after pulmonary metastasectomy in patients with renal cell carcinoma. J. Urol. 184(5), 1888–1894 (2010).
   Google Scholar
• Meimarakis G, Angele M, Staehler M et al. Evaluation of a new prognostic score (Munich score) to predict long-term survival after resection of pulmonary renal cell carcinoma metastases. Am. J. Surg. 202(2), 158–167 (2011).
   PubMed Web of Science ®Google Scholar
• Wroñski M, Arbit E, Russo P, Galicich JH. Surgical resection of brain metastases from renal cell carcinoma in 50 patients. Urology, 47(2), 187–193 (1996).
   PubMed Web of Science ®Google Scholar
• Pomer S, Klopp M, Steiner HH, Brkovic D, Staehler G, Cabillin-Engenhart R. [Brain metastases in renal cell carcinoma. Results of treatment and prognosis]. Urologe A 36(2), 117–125 (1997).
   Google Scholar